-
Mashup Score: 4Collaborative Structural Reforms Represent a Way Forward for Oncology Innovations: With Elizabeth Mittendorf, MD, PhD, MHCM - 6 day(s) ago
Dr Mittendorf shares how ASCO plans to address the implications of federal research funding cuts and how structural reforms may bolster oncology progress.
Source: www.onclive.comCategories: General Medicine NewsTweet
-
Mashup Score: 4FDA Approval Insights: Subcutaneous Nivolumab for Advanced Solid Tumors: With Roxana S. Dronca, MD - 5 month(s) ago
Dr Dronca discusses the FDA approval of subcutaneous nivolumab and hyaluronidase for advanced or metastatic solid tumors.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
In today's episode of #OncLiveOnAir, Roxana S. Dronca, MD, discusses the FDA approval of subcutaneous nivolumab and hyaluronidase for advanced or metastatic solid tumors. @RDroncaDr @MayoClinic #Oncology #MedEd LISTEN: https://t.co/TGRwdVr7un https://t.co/cGqS71Pwjh
-
-
Mashup Score: 3Revisit Every OncLive On Air Episode From November 2024 - 6 month(s) ago
In case you missed any, read a recap of every episode of OncLive On Air that aired in November 2024.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
In case you missed any, read a recap of every episode of OncLive On Air that aired in November 2024. #OncLiveOnAir #oncology #MedEd https://t.co/D2ptm3kv7c
-
-
Mashup Score: 3Revisit Every OncLive On Air Episode From November 2024 - 6 month(s) ago
In case you missed any, read a recap of every episode of OncLive On Air that aired in November 2024.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
In case you missed any, read a recap of every episode of OncLive On Air that aired in November 2024. #OncLiveOnAir #oncology #MedEd https://t.co/D2ptm3kv7c
-
-
Mashup Score: 5FDA Approval Insights: Vorasidenib in IDH1/2+ Grade 2 Astrocytoma and Oligodendroglioma - 8 month(s) ago
Dr Taylor discusses the significance of the FDA approval of vorasidenib for patients with IDH-positive grade 2 astrocytoma or oligodendroglioma.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
THIS JUST IN: In this episode of #OncLiveOnAir, Dr @JennieWTaylor, of @UCSFCancer, discusses the significance of the FDA approval of vorasidenib for patients with IDH+ grade 2 astrocytoma or oligodendroglioma. #Oncology #MedEd https://t.co/eMYXf9R6mj https://t.co/bLeDdDSs0K
-
-
Mashup Score: 5FDA Approval Insights: Vorasidenib in IDH1/2+ Grade 2 Astrocytoma and Oligodendroglioma - 8 month(s) ago
Dr Taylor discusses the significance of the FDA approval of vorasidenib for patients with IDH-positive grade 2 astrocytoma or oligodendroglioma.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
THIS JUST IN: In this episode of #OncLiveOnAir, Dr @JennieWTaylor, of @UCSFCancer, discusses the significance of the FDA approval of vorasidenib for patients with IDH+ grade 2 astrocytoma or oligodendroglioma. #Oncology #MedEd https://t.co/eMYXf9R6mj https://t.co/bLeDdDSs0K
-
-
Mashup Score: 5FDA Approval Insights: Vorasidenib in IDH1/2+ Grade 2 Astrocytoma and Oligodendroglioma - 8 month(s) ago
Dr Taylor discusses the significance of the FDA approval of vorasidenib for patients with IDH-positive grade 2 astrocytoma or oligodendroglioma.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
THIS JUST IN: In this episode of #OncLiveOnAir, Dr @JennieWTaylor, of @UCSFCancer, discusses the significance of the FDA approval of vorasidenib for patients with IDH+ grade 2 astrocytoma or oligodendroglioma. #Oncology #MedEd https://t.co/eMYXf9R6mj https://t.co/bLeDdDSs0K
-
-
Mashup Score: 0Revisit Every OncLive On Air Episode From August 2024 - 9 month(s) ago
In case you missed any, below is a recap of every OncLive On Air episode that aired in August 2024.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Revisit Every #OncLiveOnAir Episode From August 2024 #oncology #MedEd https://t.co/9SEXRK3LDc
-
-
Mashup Score: 0Revisit Every OncLive On Air Episode From August 2024 - 10 month(s) ago
In case you missed any, below is a recap of every OncLive On Air episode that aired in August 2024.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Revisit Every #OncLiveOnAir Episode From August 2024 #oncology #MedEd https://t.co/9SEXRK3LDc
-
-
Mashup Score: 3Dietrich and Shiller Dive Into the Importance of Oncology Reflex Testing - 12 month(s) ago
Drs Dietrich and Shiller detail the importance of collaboration between medical oncologists and pathologists to ensure beneficial oncology reflex testing.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
In this episode of #OncLiveOnAir, Drs @DoctorDietrich and Shiller detail the importance of collaboration between medical oncologists and pathologists to ensure beneficial oncology reflex testing. #oncology #meded https://t.co/mVYyHSaEnf https://t.co/JNc6Gea60c
-
In this episode of #OncLiveOnAir🎙️, @EMittendorfMD shares how @ASCO plans to address the implications of federal research funding cuts and how structural reforms may bolster oncology progress. #oncology #MedEd Listen now! 🎧: https://t.co/D0pEv7SYlJ https://t.co/9Em2CNULrE